Role of transcription factors in cell replacement therapies for neurodegenerative conditions

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

Bibliography

• 1  Hosing C, Saliba RM, Mclaughlin P et al.: Long-term results favor allogeneic over autologous hematopoietic stem cell transplantation in patients with refractory or recurrent indolent non-hodgkin’s lymphoma. Ann. Oncol.14(5),737–744 (2003).
  Medline CASGoogle Scholar
• 2  Couri CE, Oliveira MC, Stracieri AB et al.: C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed Type 1 diabetes mellitus. JAMA301(15),1573–1579 (2009).
  Medline CASGoogle Scholar
• 3  Voltarelli JC, Couri CE, Stracieri AB et al.: Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed Type 1 diabetes mellitus. JAMA297(14),1568–1576 (2007).
  Medline CASGoogle Scholar
• 4  Buchholz DE, Hikita ST, Rowland TJ et al.: Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells. Stem Cells27(10),2427–2434 (2009).
  Medline CASGoogle Scholar
• 5  Tezel TH, Del Priore LV, Berger AS, Kaplan HJ: Adult retinal pigment epithelial transplantation in exudative age-related macular degeneration. Am. J. Ophthalmol.143(4),584–595 (2007).
  MedlineGoogle Scholar
• 6  Ericson J, Morton S, Kawakami A, Roelink H, Jessell TM: Two critical periods of sonic hedgehog signaling required for the specification of motor neuron identity. Cell87(4),661–673 (1996).
  Medline CASGoogle Scholar
• 7  Wurst W, Bally-Cuif L: Neural plate patterning: upstream and downstream of the isthmic organizer. Nat. Rev. Neurosci.2(2),99–108 (2001).
  Medline CASGoogle Scholar
• 8  Staudt N, Houart C: The prethalamus is established during gastrulation and influences diencephalic regionalization. PLoS Biol.5(4),e69 (2007).
  MedlineGoogle Scholar
• 9  Puelles L, Martinez-De-La-Torre M, Paxinos G, Watson C, Martinez S: The Chick Brain in Stereotaxic Coordinates (1st Edition). Academic Press, CA, USA (2007).
  Google Scholar
• 10  Muller CW: Transcription factors: global and detailed views. Curr. Opin. Struct. Biol.11(1),26–32 (2001).
  Medline CASGoogle Scholar
• 11  Ouzounis CA, Papavassiliou AG: DNA-Binding Motifs of Eukaryotic Transcription Factors. Landes Bioscience, Austin, TX, USA 1–13 (1997).
  Google Scholar
• 12  Barker RA, Dunnett SB: Functional integration of neural grafts in Parkinson’s disease. Nat. Neurosci.2(12),1047–1048 (1999).
  Medline CASGoogle Scholar
• 13  Freed CR, Breeze RE, Rosenberg NL et al.: Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson’s disease. N. Engl. J. Med.327(22),1549–1555 (1992).
  Medline CASGoogle Scholar
• 14  Piccini P, Brooks DJ, Bjorklund A et al.: Dopamine release from nigral transplants visualized in vivo in a Parkinson’s patient. Nat. Neurosci.2(12),1137–1140 (1999).▪▪ Demonstrates that nigral grafts into a patient with Parkinson’s disease release dopamine and exert functional improvements, thus providing proof-of-princple that cell replacement therapies are a feasible treatment option.
  Medline CASGoogle Scholar
• 15  Kuan WL, Lin R, Tyers P, Barker RA: The importance of A9 dopaminergic neurons in mediating the functional benefits of fetal ventral mesencephalon transplants and levodopa-induced dyskinesias. Neurobiol. Dis.25(3),594–608 (2007).
  Medline CASGoogle Scholar
• 16  Thompson L, Barraud P, Andersson E, Kirik D, Bjorklund A: Identification of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections. J. Neurosci.25(27),6467–6477 (2005).▪ Following less than favorable US Phase I clinical trials of nigral transplants for Parkinson’s disease patients, identifying different subtypes of cells within grafts and their accountability for variations in functional outcomes is an important progression for this field.
  Medline CASGoogle Scholar
• 17  Wijeyekoon R, Barker RA: Cell replacement therapy for Parkinson’s disease. Biochim. Biophys. Acta1792(7),688–702 (2009).
  Medline CASGoogle Scholar
• 18  Park CH, Minn YK, Lee JY et al.: In vitro and in vivo analyses of human embryonic stem cell-derived dopamine neurons. J. Neurochem.92(5),1265–1276 (2005).
  Medline CASGoogle Scholar
• 19  Perrier AL, Tabar V, Barberi T et al.: Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc. Natl Acad. Sci. USA101(34),12543–12548 (2004).
  Medline CASGoogle Scholar
• 20  Zeng X, Cai J, Chen J et al.: Dopaminergic differentiation of human embryonic stem cells. Stem Cells22(6),925–940 (2004).
  Medline CASGoogle Scholar
• 21  Chen Q, Long Y, Yuan X et al.: Protective effects of bone marrow stromal cell transplantation in injured rodent brain: Synthesis of neurotrophic factors. J. Neurosci. Res.80(5),611–619 (2005).
  Medline CASGoogle Scholar
• 22  Crigler L, Robey RC, Asawachaicharn A, Gaupp D, Phinney DG: Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp. Neurol.198(1),54–64 (2006).
  Medline CASGoogle Scholar
• 23  Vazin T, Chen J, Lee CT, Amable R, Freed WJ: Assessment of stromal-derived inducing activity in the generation of dopaminergic neurons from human embryonic stem cells. Stem Cells26(6),1517–1525 (2008).
  MedlineGoogle Scholar
• 24  Vazin T, Becker KG, Chen J et al.: A novel combination of factors, termed spie, which promotes dopaminergic neuron differentiation from human embryonic stem cells. PLoS One4(8),e6606 (2009).
  MedlineGoogle Scholar
• 25  Davis RL, Weintraub H, Lassar AB: Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell51(6),987–1000 (1987).
  Medline CASGoogle Scholar
• 26  Takahashi K, Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell126(4),663–676 (2006).▪▪ The generation of induced pluripotent stem cells (iPSCs) from fibroblasts has completely revolutionized the field of cell replacement therapies.
  Medline CASGoogle Scholar
• 27  Takahashi K, Tanabe K, Ohnuki M et al.: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell131(5),861–872 (2007).▪▪ The generation of iPSCs from fibroblasts has completely revolutionized the field of cell replacement therapies.
  Medline CASGoogle Scholar
• 28  Yu J, Vodyanik MA, Smuga-Otto K et al.: Induced pluripotent stem cell lines derived from human somatic cells. Science318(5858),1917–1920 (2007).▪▪ The generation of iPSC from fibroblasts has completely revolutionized the field of cell replacement therapies.
  Medline CASGoogle Scholar
• 29  Nagy A, Nagy K: The mysteries of induced pluripotency: where will they lead? Nat. Methods7(1),22–24 (2010).
  Medline CASGoogle Scholar
• 30  Marchand R, Poirier LJ: Isthmic origin of neurons of the rat substantia nigra. Neuroscience9(2),373–381 (1983).
  Medline CASGoogle Scholar
• 31  Wallen A, Perlmann T: Transcriptional control of dopamine neuron development. Ann. NY Acad. Sci.991,48–60 (2003).
  Medline CASGoogle Scholar
• 32  Puelles L, Rubenstein JL: Forebrain gene expression domains and the evolving prosomeric model. Trends Neurosci.26(9),469–476 (2003).
  Medline CASGoogle Scholar
• 33  Boyer LA, Lee TI, Cole MF et al.: Core transcriptional regulatory circuitry in human embryonic stem cells. Cell122(6),947–956 (2005).
  Medline CASGoogle Scholar
• 34  Chew JL, Loh YH, Zhang W et al.: Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the Oct4/Sox2 complex in embryonic stem cells. Mol. Cell. Biol.25(14),6031–6046 (2005).
  Medline CASGoogle Scholar
• 35  Mitsui K, Tokuzawa Y, Itoh H et al.: The homeoprotein nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell113(5),631–642 (2003).
  Medline CASGoogle Scholar
• 36  Nishikawa S-I, Jakt LM, Era T: Embryonic stem-cell culture as a tool for developmental cell biology. Nat. Rev. Mol. Cell. Biol.8(6),502–507 (2007).
  Medline CASGoogle Scholar
• 37  Woltjen K, Michael IP, Mohseni P et al.: Piggybac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature458(7239),766–770 (2009).
  Medline CASGoogle Scholar
• 38  Nichols J, Zevnik B, Anastassiadis K et al.: Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell95(3),379–391 (1998).
  Medline CASGoogle Scholar
• 39  Sommer CA, Stadtfeld M, Murphy GJ, Hochedlinger K, Kotton DN, Mostoslavsky G: Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells27(3),543–549 (2009).
  Medline CASGoogle Scholar
• 40  Wernig M, Meissner A, Foreman R et al.: In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature448(7151),318–324 (2007).
  Medline CASGoogle Scholar
• 41  Wernig M, Meissner A, Cassady JP, Jaenisch R: C-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell2(1),10–12 (2008).
  Medline CASGoogle Scholar
• 42  Bertrand N, Castro DS, Guillemot F: Proneural genes and the specification of neural cell types. Nat. Rev. Neurosci.3(7),517–530 (2002).
  Medline CASGoogle Scholar
• 43  Ostenfeld T, Joly E, Tai YT et al.: Regional specification of rodent and human neurospheres. Brain Res. Dev. Brain Res.134(1–2),43–55 (2002).
  Medline CASGoogle Scholar
• 44  Parmar M, Skogh C, Bjorklund A, Campbell K: Regional specification of neurosphere cultures derived from subregions of the embryonic telencephalon. Mol. Cell Neurosci.21(4),645–656 (2002).
  Medline CASGoogle Scholar
• 45  Hitoshi S, Tropepe V, Ekker M, Van Der Kooy D: Neural stem cell lineages are regionally specified, but not committed, within distinct compartments of the developing brain. Development129(1),233–244 (2002).
  Medline CASGoogle Scholar
• 46  Ericson J, Rashbass P, Schedl A et al.: Pax6 controls progenitor cell identity and neuronal fate in response to graded Shh signaling. Cell90(1),169–180 (1997).
  Medline CASGoogle Scholar
• 47  Stoykova A, Gruss P: Roles of Pax-genes in developing and adult brain as suggested by expression patterns. J. Neurosci.14(3 Pt 2),1395–1412 (1994).
  Medline CASGoogle Scholar
• 48  Tanabe Y, Jessell TM: Diversity and pattern in the developing spinal cord. Science274(5290),1115–1123 (1996).
  Medline CASGoogle Scholar
• 49  Lee SK, Pfaff SL: Transcriptional networks regulating neuronal identity in the developing spinal cord. Nat. Neurosci.4(Suppl.),1183–1191 (2001).
  Medline CASGoogle Scholar
• 50  Kittappa R, Chang WW, Awatramani RB, Mckay RD: The foxa2 gene controls the birth and spontaneous degeneration of dopamine neurons in old age. PLoS Biol.5(12),e325 (2007).
  MedlineGoogle Scholar
• 51  Rhinn M, Dierich A, Le Meur M, Ang S: Cell autonomous and non-cell autonomous functions of Otx2 in patterning the rostral brain. Development126(19),4295–4304 (1999).
  Medline CASGoogle Scholar
• 52  Araki I, Nakamura H: Engrailed defines the position of dorsal di-mesencephalic boundary by repressing diencephalic fate. Development126(22),5127–5135 (1999).
  Medline CASGoogle Scholar
• 53  Matsunaga E, Araki I, Nakamura H: Pax6 defines the di-mesencephalic boundary by repressing En1 and Pax2. Development127(11),2357–2365 (2000).
  Medline CASGoogle Scholar
• 54  Crossley PH, Martinez S, Martin GR: Midbrain development induced by FGF8 in the chick embryo. Nature380(6569),66–68 (1996).
  Medline CASGoogle Scholar
• 55  Shamim H, Mahmood R, Logan C, Doherty P, Lumsden A, Mason I: Sequential roles for FGF4, En1 and FGF8 in specification and regionalisation of the midbrain. Development126(5),945–959 (1999).
  Medline CASGoogle Scholar
• 56  Simeone A, Acampora D, Gulisano M, Stornaiuolo A, Boncinelli E: Nested expression domains of four homeobox genes in developing rostral brain. Nature358(6388),687–690 (1992).
  Medline CASGoogle Scholar
• 57  Wassarman KM, Lewandoski M, Campbell K et al.: Specification of the anterior hindbrain and establishment of a normal mid/hindbrain organizer is dependent on gbx2 gene function. Development124(15),2923–2934 (1997).
  Medline CASGoogle Scholar
• 58  Broccoli V, Boncinelli E, Wurst W: The caudal limit of otx2 expression positions the isthmic organizer. Nature401(6749),164–168 (1999).
  Medline CASGoogle Scholar
• 59  Scholpp S, Lohs C, Brand M: Engrailed and FGF8 act synergistically to maintain the boundary between diencephalon and mesencephalon. Development130(20),4881–4893 (2003).
  Medline CASGoogle Scholar
• 60  Okafuji T, Funahashi J, Nakamura H: Roles of Pax-2 in initiation of the chick tectal development. Brain Res. Dev. Brain Res.116(1),41–49 (1999).
  Medline CASGoogle Scholar
• 61  Funahashi J, Okafuji T, Ohuchi H, Noji S, Tanaka H, Nakamura H: Role of Pax-5 in the regulation of a mid-hindbrain organizer’s activity. Dev. Growth Differ.41(1),59–72 (1999).
  Medline CASGoogle Scholar
• 62  Lee SM, Danielian PS, Fritzsch B, McMahon AP: Evidence that FGF8 signalling from the midbrain-hindbrain junction regulates growth and polarity in the developing midbrain. Development124(5),959–969 (1997).
  Medline CASGoogle Scholar
• 63  Nakamura H: Regionalization of the optic tectum: combinations of gene expression that define the tectum. Trends Neurosci.24(1),32–39 (2001).
  Medline CASGoogle Scholar
• 64  Mastick GS, Davis NM, Andrew GL, Easter SS Jr: Pax-6 functions in boundary formation and axon guidance in the embryonic mouse forebrain. Development124(10),1985–1997 (1997).
  Medline CASGoogle Scholar
• 65  Thompson JA, Lovicu FJ, Ziman M: Pax7 and superior collicular polarity: insights from Pax6 (Sey) mutant mice. Exp. Brain Res.178(3),316–325 (2007).
  MedlineGoogle Scholar
• 66  Matsunaga E, Araki I, Nakamura H: Role of Pax3/7 in the tectum regionalization. Development128(20),4069–4077 (2001).
  Medline CASGoogle Scholar
• 67  Abeliovich A, Hammond R: Midbrain dopamine neuron differentiation: factors and fates. Dev. Biol.304(2),447–454 (2007).
  Medline CASGoogle Scholar
• 68  Perlmann T, Wallen-Mackenzie A: Nurr1, an orphan nuclear receptor with essential functions in developing dopamine cells. Cell Tissue Res.318(1),45–52 (2004).
  Medline CASGoogle Scholar
• 69  Levesque D, Rouillard C: Nur77 and retinoid X receptors: crucial factors in dopamine-related neuroadaptation. Trends Neurosci.30(1),22–30 (2007).
  Medline CASGoogle Scholar
• 70  Prakash N, Wurst W: Development of dopaminergic neurons in the mammalian brain. Cell. Mol. Life Sci.63(2),187–206 (2006).
  Medline CASGoogle Scholar
• 71  Chung S, Sonntag KC, Andersson T et al.: Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons. Eur. J. Neurosci.16(10),1829–1838 (2002).
  MedlineGoogle Scholar
• 72  Kim JH, Auerbach JM, Rodriguez-Gomez JA et al.: Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson’s disease. Nature418(6893),50–56 (2002).▪ Demonstrates the potential for the application of stem cells to generate dopamine-producing neurons that can be utilized in the treatment of Parkinson’s disease.
  Medline CASGoogle Scholar
• 73  Sonntag KC, Simantov R, Kim KS, Isacson O: Temporally induced Nurr1 can induce a non-neuronal dopaminergic cell type in embryonic stem cell differentiation. Eur. J. Neurosci.19(5),1141–1152 (2004).
  MedlineGoogle Scholar
• 74  Smidt MP, Burbach JPH: How to make a mesodiencephalic dopaminergic neuron. Nat. Rev. Neurosci.8(1),21–32 (2007).
  Medline CASGoogle Scholar
• 75  Smidt MP, Smits SM, Burbach JP: Molecular mechanisms underlying midbrain dopamine neuron development and function. Eur. J. Pharmacol.480(1–3),75–88 (2003).
  Medline CASGoogle Scholar
• 76  Smidt MP, Smits SM, Bouwmeester H et al.: Early developmental failure of substantia nigra dopamine neurons in mice lacking the homeodomain gene Pitx3. Development131,1145–1155 (2004).
  Medline CASGoogle Scholar
• 77  Fluri DA, Baba MD, Fussenegger M: Adeno-associated viral vectors engineered for macrolide-adjustable transgene expression in mammalian cells and mice. BMC Biotechnol.7,75 (2007).
  MedlineGoogle Scholar
• 78  Varas F, Stadtfeld M, De Andres-Aguayo L et al.: Fibroblast-derived induced pluripotent stem cells show no common retroviral vector insertions. Stem Cells27(2),300–306 (2009).
  Medline CASGoogle Scholar
• 79  Zhou W, Freed CR: Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells. Stem Cells27(11),2667–2674 (2009).▪▪ While the advent of iPSCs has revolutionarized the field of cell replacement therapies, the delivery of key genetic factors will influence the future success and clinical translation. Development of technologies that enable the safe, predictable and controllable delivery of core genetic factors will be critical.
  Medline CASGoogle Scholar
• 80  Collinson JM, Chanas SA, Hill RE, West JD: Corneal development, limbal stem cell function, and corneal epithelial cell migration in the Pax6^+/- mouse. Invest. Ophthalmol. Vis. Sci.45(4),1101–1108 (2004).
  MedlineGoogle Scholar
• 81  Lesaffre B, Joliot A, Prochiantz A, Volovitch M: Direct non-cell autonomous Pax6 activity regulates eye development in the zebrafish. Neural Develop.2,2 (2007).
  MedlineGoogle Scholar
• 82  Prochiantz A, Joliot A: Can transcription factors function as cell–cell signalling molecules? Nat. Rev. Mol. Cell. Biol.4(10),814–819 (2003).▪▪ While the advent of iPSCs has revolutionarized the field of cell replacement therapies, the delivery of key genetic factors will influence the future success and clinical translation. Development of technologies that enable the safe, predictable and controllable delivery of core genetic factors will be critical.
  Medline CASGoogle Scholar
• 83  Thomas M, Tyers P, Lazic SE, Barker RA, Beazley L, Ziman M: Graft outcomes influenced by co-expression of Pax7 in graft and host tissue. J. Anat.214(3),396–405 (2009).
  MedlineGoogle Scholar